Innovating to improve health worldwide

We are the voice of the innovative pharmaceutical industry, collaborating for global health progress to improve lives everywhere.

Areas of work About us
A female and male pharmacist discussing medication

Latest news

Press release 17 June 2026

Pharmaceutical industry mobilizes to support response to the Ebola Bundibugyo virus disease outbreak and calls for a system that enables rapid response and sustained R&D investment

The global pharmaceutical industry underlines the commitment of the sector to support the response to the latest Ebolavirus outbreak, and calls for the latest outbreak to be a “wake up call” for negotiators discussing the details of the Pandemic Agreement.

Read more
Statement 16 June 2026

High-Level Virtual Meeting of African Heads of States, Governments and Partners on Ebola Bundibugyo virus disease outbreak

IFPMA Statement ahead of the High-Level Meeting of African Heads of State, Governments and Partners on the Ebola Bundibugyo virus disasese outbreak.

Read more
Infographic 16 June 2026

Adult immunization for healthy workforces and healthy economies in an aging world

IFPMA and the Global Coalition on Ageing (GCOA) outline why vaccination is essential to building healthier workforces and stronger economies in an aging world.

Read more
Expert insights 11 June 2026

The G7 cannot afford to lose its leadership in pharmaceutical innovation

Whilst G7 countries have long been the traditional home of pharmaceutical innovation, there is increased global competition, and there is a real risk that this longstanding leadership will be lost without concerted action. Ahead of the G7 Leaders’ Summit in Evian on 15-17 June 2026, David Reddy, Director General of IFPMA, stresses that sustaining innovation leadership must be a strategic priority in a rapidly evolving landscape.

Read more
Press release 11 June 2026

Pharmaceutical industry calls on G7 to invest in innovation to drive competitiveness, resilience, and growth

IFPMA and Leem call on G7 leaders to place pharmaceutical innovation at the centre of their economic and competitiveness agenda.

Read more
Press release
Pharmaceutical industry mobilizes to support response to the Ebola Bundibugyo virus disease outbreak and calls for a system that enables rapid response and sustained R&D investment
Statement
High-Level Virtual Meeting of African Heads of States, Governments and Partners on Ebola Bundibugyo virus disease outbreak
Infographic
Adult immunization for healthy workforces and healthy economies in an aging world
Expert insights
The G7 cannot afford to lose its leadership in pharmaceutical innovation
Press release
Pharmaceutical industry calls on G7 to invest in innovation to drive competitiveness, resilience, and growth

Initiatives

See all

#AlwaysInnovating

Investing in innovative medicines and vaccines doesn’t just save lives – it transforms our future. It strengthens health, drives economic growth, and improves health security.

Read more

#VaccinesForLife

Investing in adult vaccination programmes can help protect lives, our healthcare systems, and our economies. Read the new report by the Office of Health Economics to discover more.

Read more

#AlwaysInnovating

#AlwaysInnovating lifts the curtain on the innovation journey, revealing the knowledge, skills, collaboration, and perseverance needed to turn an idea into a medicine or vaccine that brings hope to people everywhere.

Read more

Global Health Progress

Explore how the innovative pharmaceutical industry is collaborating across global health actors to support the Sustainable Development Goals in low- and middle-income countries.

Visit microsite
#VaccinesForLife skyscraper
#alwaysinnovating campaign image - an illustration of a microscope with a lightbulb
Global Health Progress campaign image - a group of children in front of the SDG wheel
A female lab technician looking through a microscope

Collaborating for global health progress

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents the innovative pharmaceutical industry at the international level and in official relations with the United Nations.

About us

Areas of work

See all
Lightbulb

Fostering a thriving health innovation ecosystem
Heart

Advancing sustainable health systems
Mask

Improving health security and pandemic preparedness
Document

Strengthening regulatory systems
Scales

Upholding ethics and business integrity
Africa

Supporting Africa’s health ecosystem  

Our members

Representing over 90 of the most forward-looking companies and associations in the world.

See all
AstraZeneca logo
Pfizer logo
Grünenthal logo
Abbvie logo
Otsuka logo
Novartis logo
Lilly logo
Top